Insufficient scRNA-seq data for expression of DACT1 at single-cell level.
Insufficient scRNA-seq data for expression of DACT1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 1396.17 | 241 / 245 | 89% | 6.98 | 448 / 502 |
breast | 95% | 1071.95 | 434 / 459 | 92% | 12.06 | 1031 / 1118 |
thymus | 100% | 1791.90 | 651 / 653 | 86% | 8.41 | 523 / 605 |
lung | 98% | 1346.40 | 564 / 578 | 83% | 7.28 | 953 / 1155 |
intestine | 92% | 804.98 | 888 / 966 | 85% | 8.11 | 450 / 527 |
bladder | 100% | 1489.00 | 21 / 21 | 66% | 6.01 | 331 / 504 |
stomach | 82% | 738.37 | 294 / 359 | 82% | 9.64 | 235 / 286 |
brain | 66% | 849.64 | 1748 / 2642 | 92% | 6.43 | 650 / 705 |
ovary | 100% | 2826.09 | 180 / 180 | 54% | 3.15 | 231 / 430 |
uterus | 96% | 1001.95 | 164 / 170 | 54% | 6.44 | 247 / 459 |
kidney | 81% | 668.72 | 72 / 89 | 68% | 6.21 | 612 / 901 |
adrenal gland | 90% | 695.20 | 233 / 258 | 49% | 2.92 | 112 / 230 |
esophagus | 61% | 473.01 | 876 / 1445 | 68% | 5.97 | 125 / 183 |
pancreas | 23% | 122.84 | 77 / 328 | 93% | 15.42 | 166 / 178 |
skin | 46% | 274.48 | 837 / 1809 | 67% | 5.52 | 317 / 472 |
blood vessel | 100% | 3066.97 | 1333 / 1335 | 0% | 0 | 0 / 0 |
spleen | 98% | 932.19 | 235 / 241 | 0% | 0 | 0 / 0 |
adipose | 94% | 1167.07 | 1132 / 1204 | 0% | 0 | 0 / 0 |
heart | 65% | 558.11 | 561 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 3.14 | 17 / 29 |
liver | 24% | 105.72 | 55 / 226 | 28% | 1.36 | 114 / 406 |
tonsil | 0% | 0 | 0 / 0 | 36% | 2.34 | 16 / 45 |
muscle | 22% | 118.24 | 176 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 13% | 135.19 | 125 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 11% | 0.34 | 9 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_1900107 | Biological process | regulation of nodal signaling pathway |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0048619 | Biological process | embryonic hindgut morphogenesis |
GO_0030178 | Biological process | negative regulation of Wnt signaling pathway |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_2000095 | Biological process | regulation of Wnt signaling pathway, planar cell polarity pathway |
GO_1904864 | Biological process | negative regulation of beta-catenin-TCF complex assembly |
GO_2000134 | Biological process | negative regulation of G1/S transition of mitotic cell cycle |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0032091 | Biological process | negative regulation of protein binding |
GO_0021915 | Biological process | neural tube development |
GO_0060828 | Biological process | regulation of canonical Wnt signaling pathway |
GO_0030177 | Biological process | positive regulation of Wnt signaling pathway |
GO_0031647 | Biological process | regulation of protein stability |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030877 | Cellular component | beta-catenin destruction complex |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0070097 | Molecular function | delta-catenin binding |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0061629 | Molecular function | RNA polymerase II-specific DNA-binding transcription factor binding |
GO_0051018 | Molecular function | protein kinase A binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | DACT1 |
Protein name | Dapper homolog 1 (hDPR1) (Dapper antagonist of catenin 1) (Hepatocellular carcinoma novel gene 3 protein) Dishevelled binding antagonist of beta catenin 1 (cDNA FLJ51077, highly similar to Dapper homolog 1) (cDNA, FLJ79063, highly similar to Dapper homolog 1) (cDNA, FLJ79136, highly similar to Dapper homolog 1) Dishevelled binding antagonist of beta catenin 1 |
Synonyms | DPR1 HNG3 |
Description | FUNCTION: Involved in regulation of intracellular signaling pathways during development. Specifically thought to play a role in canonical and/or non-canonical Wnt signaling pathways through interaction with DSH (Dishevelled) family proteins. The activation/inhibition of Wnt signaling may depend on the phosphorylation status. Proposed to regulate the degradation of CTNNB1/beta-catenin, thereby modulating the transcriptional activation of target genes of the Wnt signaling pathway. Its function in stabilizing CTNNB1 may involve inhibition of GSK3B activity. Promotes the membrane localization of CTNNB1. The cytoplasmic form can induce DVL2 degradation via a lysosome-dependent mechanism; the function is inhibited by PKA-induced binding to 14-3-3 proteins, such as YWHAB. Seems to be involved in morphogenesis at the primitive streak by regulating VANGL2 and DVL2; the function seems to be independent of canonical Wnt signaling and rather involves the non-canonical Wnt/planar cell polarity (PCP) pathway (By similarity). The nuclear form may prevent the formation of LEF1:CTNNB1 complex and recruit HDAC1 to LEF1 at target gene promoters to repress transcription thus antagonizing Wnt signaling. May be involved in positive regulation of fat cell differentiation. During neuronal differentiation may be involved in excitatory synapse organization, and dendrite formation and establishment of spines. . |
Accessions | ENST00000707126.1 [Q9NYF0-2] Q9NYF0 ENST00000541264.2 B7Z673 C9JGV7 ENST00000556859.5 ENST00000395153.8 [Q9NYF0-2] ENST00000335867.4 [Q9NYF0-1] ENST00000421793.5 |